These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38879067)

  • 1. Pharmacotherapeutic value of inflammatory and neurotrophic biomarkers in bipolar disorder: A systematic review.
    Ruiz-Sastre P; Gómez-Sánchez-Lafuente C; Martín-Martín J; Herrera-Imbroda J; Mayoral-Cleries F; Santos-Amaya I; Rodríguez de Fonseca F; Guzmán-Parra J; Rivera P; Suárez J
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Aug; 134():111056. PubMed ID: 38879067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing patterns of antidepressants, antipsychotics and mood stabilizers in bipolar patients misdiagnosed with major depressive disorder in China.
    Xiang YT; Hu C; Wang G; Zheng QW; Fang YR; Ungvari GS; Kilbourne AM; Lai KY; Si TM; Chen DF; Lu Z; Yang HC; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
    Hum Psychopharmacol; 2012 Nov; 27(6):626-31. PubMed ID: 23027671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of manic/hypomanic and depressive switches in patients with bipolar disorder in naturalistic settings: The role of antidepressant and antipsychotic drugs.
    Barbuti M; Menculini G; Verdolini N; Pacchiarotti I; Kotzalidis GD; Tortorella A; Vieta E; Perugi G
    Eur Neuropsychopharmacol; 2023 Aug; 73():1-15. PubMed ID: 37119556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-conventional pharmacological agents for the treatment of bipolar disorder: Α systematic review of the evidence].
    Fountoulakis KN; Balaris D; Nikolaou V; Νimatoudis J
    Psychiatriki; 2016; 27(4):253-263. PubMed ID: 28114089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review.
    Buoli M; Serati M; Altamura AC
    J Affect Disord; 2014 Jan; 152-154():12-8. PubMed ID: 24041717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The armamentarium of treatments for bipolar disorder: a review of the literature.
    Cousins DA; Young AH
    Int J Neuropsychopharmacol; 2007 Jun; 10(3):411-31. PubMed ID: 17176493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the immune system in the treatment of bipolar disorder.
    Rosenblat JD
    Psychopharmacology (Berl); 2019 Oct; 236(10):2909-2921. PubMed ID: 30756134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Effects of Antidepressants in Association With Mood Stabilizers and/or Antipsychotics in Unipolar and Bipolar Depression.
    Moderie C; Nuñez N; Comai S; Saint-Laurent M; Fielding A; Low N; Gobbi G
    J Clin Psychopharmacol; 2022 Mar-Apr 01; 42(2):118-124. PubMed ID: 35067518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review.
    van den Ameele S; van Diermen L; Staels W; Coppens V; Dumont G; Sabbe B; Morrens M
    J Affect Disord; 2016 Oct; 203():364-373. PubMed ID: 27344047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review.
    Amerio A; Maina G; Ghaemi SN
    J Affect Disord; 2019 Sep; 256():433-440. PubMed ID: 31234022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Serum Uric Acid in Major Depressive Disorder and Bipolar Disorder: a Retrospective Chart Review Study.
    Kim S; Rhee SJ; Song Y; Ahn YM
    J Korean Med Sci; 2020 Jul; 35(28):e222. PubMed ID: 32686367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of adult bipolar disorder.
    Baldessarini RJ; Tondo L; Vázquez GH
    Mol Psychiatry; 2019 Feb; 24(2):198-217. PubMed ID: 29679069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey.
    Shinozaki M; Yasui-Furukori N; Adachi N; Ueda H; Hongo S; Azekawa T; Kubota Y; Katsumoto E; Edagawa K; Goto E; Miki K; Kato M; Nakagawa A; Kikuchi T; Tsuboi T; Watanabe K; Shimoda K; Yoshimura R
    Asian J Psychiatr; 2022 Jan; 67():102935. PubMed ID: 34844178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.
    Goldberg JF; Brooks JO; Kurita K; Hoblyn JC; Ghaemi SN; Perlis RH; Miklowitz DJ; Ketter TA; Sachs GS; Thase ME
    J Clin Psychiatry; 2009 Feb; 70(2):155-62. PubMed ID: 19210946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world use of pharmacological treatments for incident bipolar disorder: A Finnish nationwide cohort study.
    Koistinaho A; Poranen J; Tanskanen A; Tiihonen J; Taipale H; Lähteenvuo M
    J Affect Disord; 2023 Nov; 340():237-244. PubMed ID: 37557987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bipolar disorder in adults with Asperger׳s Syndrome: a systematic review.
    Vannucchi G; Masi G; Toni C; Dell'Osso L; Erfurth A; Perugi G
    J Affect Disord; 2014 Oct; 168():151-60. PubMed ID: 25046741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmenting pharmacotherapy with neuromodulation techniques for the treatment of bipolar disorder: a focus on the effects of mood stabilizers on cortical excitability.
    Martinotti G; Montemitro C; Pettorruso M; Viceconte D; Alessi MC; Di Carlo F; Lucidi L; Picutti E; Santacroce R; Di Giannantonio M
    Expert Opin Pharmacother; 2019 Sep; 20(13):1575-1588. PubMed ID: 31150304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.